Treating Nightmares Among Domiciliary Patients

NCT04341987 | Withdrawn

• 1 other identifier: 1534869
• Study Type: interventional
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

The purpose of the study is to assess the efficacy of a 2-session intervention to reduce nightmares among Veterans admitted VA mental health residential rehabilitation treatment programs.

Conditions

Nightmare

Keywords

nightmares; treatment; substance use; imagery rehearsal therapy

Outcome Measures

Primary Outcomes (2)

• Nightmare Frequency

  Disturbing Dreams and Nightmares Severity Index. The score for frequency ranges from 0-7.

  Change in total nights with nigthmares in the past week from baseline to 8 week follow-up.

• Nightmare Severity

  Disturbing Dreams and Nightmares Severity Index. The score for severity ranges from 0-6.

  Change in nigthmare severity from baseline to 8 week follow-up.

Study Arms (2)

brief Imagery Rehearsal Therapy

EXPERIMENTAL

The brief two-session, behaviorally-based imagery rehearsal intervention is based on components from previous group and individual formats that have been published, but will be presented in an abbreviated manner. In the first session, Veterans will be presented with psychoeducation about dreaming, basics of sleep hygiene and stimulus control techniques, how to change negative dreams from a "learned habit" perspective, re-scripting, and how to rehearse new dream imagery. They will then be asked to complete in-session practice of imagery rehearsal with the new imagery developed. Veteran will be instructed in practice post-session.

Behavioral: brief Imagery Rehearsal Therapy

Treatment As Usual

OTHER

Patients in this condition are free to receive treatment as usual for nightmares, which may be a medication, supportive counseling or no treatment.

Other: Treatment As Usual

Interventions

brief Imagery Rehearsal Therapy BEHAVIORAL

Two-sessions of behaviorally-based imagery rehearsal therapy.

brief Imagery Rehearsal Therapy

Treatment As Usual OTHER

may include medication treatment or behavioral treatment for nightmares other than imagery rehearsal therapy

Treatment As Usual

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• English-speaking
• endorses nightmares at least once a week
• score of 10 or greater on the Disturbing Dreams and Nightmares Severity Index

You may not qualify if:

• unable to consent
• diagnosis of serious mental illness (schizophrenia, schizoaffective disorder)
• active suicide ideation with plan and intent

Sponsors & Collaborators

• Canandaigua VA Medical Center: lead

MeSH Terms

Conditions

Substance-Related Disorders

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Mental Disorders

Study Officials

• WIlfred R Pigeon, PhD

  Canandaigua VAMC

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: FED
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 7, 2020
• First Posted: April 10, 2020
• Study Start: January 1, 2021
• Primary Completion: June 1, 2021
• Study Completion: June 1, 2021
• Last Updated: October 22, 2020

Record last verified: 2020-10

Data Sharing

• IPD Sharing: Will not share